Lester: thanks for your recent excellent DD on the Nasdaq uplisting, which is your part time job (:). Clearly, we're a much stronger company than some ones that have successfully uplisted. I agree with you that the important point is that we have not been rejected. I have said all along that the reason is the space - CBD - combined with the usual conservatism in the finance industry. Happy to be unbelievably reckless with subprime lending, but give a profitable company in a burgeoning field a chance to uplist, well, we need to think about it. If the finance laws were changed and CBD was considered "completely legal" (OK federally, but varies state to state), we'd be in.
Like you, I believe if there were material reasons for it not to meet the requirements, they'd have been rejected. For now, we just wait and watch and hopefully creep up in stock price.
GLTY.
MT
News 
Market Data 
Discover 
